Assessing the effect of fluoxetine on the clinical symptoms and echocardiographic findings in patients with mitral valve prolapse and generalized anxiety disorder, referred to Mashhad outpatient cardiology clinics in 2015.

Sabzevar University of Medical Science0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•patients who their mitral valve prolapse (MVP) is confirmed by echocardiography and have clinical symptoms of MVP (at least must have palpitation or chest pain).Exclusion criteria: medical conditions which directly or indirectly can induce anxiety including anemia;hypercalemia;hypoglycemia;drugs or alcohol withdrawal syndrome;vertigo;thyrotoxicosis;hypercapnea;hyponatremia;central nervous system disorders such as seizures;asthma;ischemic heart disease;malignancies;drugs such as anticonvulsants;antimicrobials;broncho dilators;digitalis;estrogen;insulin;nonsteroidal anti-inflammatory drugs;antidepressants;antihistamines;calcium channel blockers;dopamine;inotropics;levodopa;thyroxine;corticosteroids;smoking;patients who dont full fill DSM-IV criteria and are not included in generalized anxiety disorder category;any other documented psychological problems;patients who are not interested in continuing medications and are willing to be excluded;patients who do not take their medications regularly;patients who are prescribed with other drugs during the study;patients who are not capable to continue study because of drug adverse effects or need to change their drugs according to physicians order.

发起方

Sabzevar University of Medical Science